Healthcare Industry News: Mitral Valve
News Release - October 26, 2010
2nd Total Artificial Heart Patient in U.S. History Discharged from the Hospital Using the Freedom(TM) Portable Driver45-Year-Old Pastor Leaves INTEGRIS Baptist Medical Center to Wait for a Matching Donor Heart at Home as Part of FDA Clinical Study
TUCSON, Ariz.--(Healthcare Sales & Marketing Network)-- On Oct. 18, 45-year-old Troy Golden (photo) became the second patient in the U.S. to leave the hospital using the Freedom™ portable driver to power his SynCardia temporary Total Artificial Heart. The pastor from Geary, Okla. was discharged from INTEGRIS Baptist Medical Center to wait for a matching donor heart at home with his family and friends.
“I'm ecstatic to go home,” Golden told the media on the day of his discharge (photo). “I'm ecstatic that this artificial heart has given me a chance to wait for a heart transplant.”
Golden is participating in an FDA-approved Investigational Device Exemption (IDE) clinical study of the 13.5 lb Freedom driver, the first portable driver designed to power SynCardia’s Total Artificial Heart both inside and outside the hospital. The IDE clinical study is designed to demonstrate that the Freedom driver is a suitable pneumatic driver for stable Total Artificial Heart patients and can be safely used at home.
“If this new technology can help prolong the lives of others suffering from end-stage heart failure and I can play a small role in it, then it will all be worth it,” said Golden.
Currently, the only FDA-approved driver for powering the Total Artificial Heart is the 418 lb “Big Blue” hospital driver. Patients supported by Big Blue are confined to the hospital until they receive a heart transplant.
Golden was born with a genetic condition called Marfan syndrome that has been slowly attacking his heart since birth. In 2006, he underwent an aortic valve replacement, an aortic root repair, a Mitral Valve replacement and the Maze rhythm procedure on his atrium. In January, he was put on the heart transplant list, but his condition continued to deteriorate, until he could barely raise his head off his pillow. On Sept. 15, he became the first person in the region to have his heart replaced with the Total Artificial Heart as a bridge to transplant. Within a month, Golden’s condition was stable enough for him to be discharged home.
“This is almost like performing a resurrection,” said Dr. James Long, cardiovascular surgeon and director of the INTEGRIS Advanced Cardiac Care program. “This is taking someone who was checking out and giving them life, and life abundantly.”
About SynCardia Systems, Inc.
SynCardia Systems, Inc. is the Tucson-based manufacturer of the world’s only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artificial Heart. There have been more than 850 implants of the Total Artificial Heart, accounting for more than 200 patient years of life on the device.
Originally used as a permanent replacement heart, the Total Artificial Heart is currently approved as a bridge to human heart transplant for people dying from end-stage biventricular failure. The Total Artificial Heart is the only device that provides immediate, safe blood flow of up to 9.5 L/min through both ventricles.
For additional information, please visit: http://www.syncardia.com or follow SynCardia on Twitter – @SynCardia_News
Source: SynCardia Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.